
    
      This is an open and off label use, interventional, single site study. The HCWP Study
      eligibility are HCWs at high risk for SARS-CoV-2 exposure (eg MD/DO, NP, RN, and respiratory
      therapists in ED, Pediatric ED, Urgent Care, Pediatric Urgent Care and on Covid-19 units) at
      UNM HEALTH SYSTEM meeting all inclusion criteria. Total number of participants: 350 (Group A
      and B) Group A: up to 275 (HCW who choose to be provided HCQ). Will receive a 600 mg loading
      dose followed by 200 mg daily (tablets).

      Group B: up to 75 (HCW who choose not to be provided HCQ)
    
  